Long Protocol and Growth Hormone in Poor Responders

• Register: ClinicalTrials.gov
• Last refreshed on: 16 December 2017
• Main ID: NCT02338206
• Date of registration: 09/01/2015
• Prospective Registration: Yes
• Primary sponsor: Woman's Health University Hospital, Egypt
• Public title: Long Protocol and Growth Hormone in Poor Responders
• Scientific title: Growth Hormone Adjuvant Therapy With Long Down Regulation Protocol in Poor Responders Undergoing In Vitro Fertilization Cycles: a Randomized Control Trial
• Date of first enrolment: March 2015
• Target sample size: 240
• Recruitment status: Completed
• URL: https://clinicaltrials.gov/show/NCT02338206
• Study type: Interventional
• Study design: Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: None (Open Label).
• Phase: Phase 2

Countries of recruitment

Egypt

Contacts

• Name: Dina M Dakhly, MD
• Affiliation: Cairo University

Key inclusion & exclusion criteria

Inclusion Criteria:

- Poor responder females are those who posses two out of these three criteria:

- Female age =40 years

- Females who have at least one previous cancelled IVF cycle

- POR according to AFC = 5 or low AMH value.

Exclusion Criteria:

- Females over 45 years

- Females with FSH more than 20 IU/l

- Females with previous ovarian surgery

- Females suffering from causes of infertility other than poor ovarian response

- Females refusing to be enrolled in the study



Age minimum: 20 Years
Age maximum: 44 Years
Gender: Female

Health Condition(s) or Problem(s) studied

Infertility

Intervention(s)

Drug: Growth hormone

Primary Outcome(s)

Live birth rate [Time Frame: 12 months]

Secondary ID(s)

LP112015

Source(s) of Monetary Support

Please refer to primary and secondary sponsors

Secondary Sponsor(s)

Cairo University